Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Phylogica, Appendix 3B, New Issue Announcement (ASX:PYC)

Please find attached and Appendix 3B and Section 708A Notice in respect of the issue of 146,166,674 ordinary fully paid shares issued pursuant to the share placement announced to ASX on 11 September 2...read more

Phylogica, Annual Financial Report 30 June 2018 (ASX:PYC)

The directors present their report on the consolidated group, comprising Phylogica Limited (referred to in these financial statements as “the Group” or “Phylogica”) and its who...read more

Phylogica, Reinstatement to Official Quotation (ASX:PYC)

The suspension of trading in the securities of Phylogica Limited (‘PYC’) will be lifted from the commencement of trading today, Wednesday, 12 September 2018, following the release by PYC o...read more

Phylogica Announces Re-capitalisation (ASX:PYC)

Phylogica is pleased to announce that it has received firm commitments to raise $9.12 m (before costs) through a placement of shares to both new and existing sophisticated and institutional investors ...read more

Pancontinental, Presentation: Giant Scale Oil Exploration Potential Spotlight on Namibia (ASX:PCL)

Corporate Snapshot - Key Statistics - Current major activities - Board Back on the Global Stage - Namibia at the forefront - Focus on modest entry cost, conventional reservoirs with exposu...read more

Pancontinental Announces Billion Barrel Oil Potential Assessed in PEL 87 Offshore Namibia (ASX:PCL)

- Giant scale oil potential in multiple Large Leads in PEL 87 - Vast Cretaceous Superfan directly on top of Mature Oil Source - Oil potential exceeding 1 Billion Barrels Recoverable - Pancontinenta...read more

Phylogica, Suspension from Official Quotation (ASX:PYC)

We refer to our request for a trading halt dated 7 September 2018. Phylogica Limited (“Phylogica, the Company”) requests that the ASX grant a voluntary suspension in the Company’s...read more

Phylogica Announces Update on Capital Raising (ASX:PYC)

Phylogica provides the following update in relation to its current capital raising. The capital raising: - is being conducted at a price of 3 cents per share; - is an excluded offer available...read more

Phylogica, Trading Halt (ASX:PYC)

In accordance with Listing Rule 17.1, Phylogica Limited requests that an immediate trading halt be placed on its securities pending an announcement to the market regarding a proposed capital raising t...read more

Phylogica, Appendix 4E, Preliminary Final Report - Year Ended 30 June 2018 (ASX:PYC)

DIRECTORS’ COMMENTARY The principal activity of the Company during the financial year was research and development. Phylogica owns a delivery platform that enables drug cargoes to reach targe...read more

Pancontinental Provides Alvares 1 Testing and Dempsey Update (ASX:PCL)

Pancontinental Oil and Gas NL (ASX:PCL) provides the attached update announcement by Operator Sacgasco Limited (ASX:SGC). Alvares Re-entry planned for early next quarter Dempsey Production Testi...read more

Phylogica Announces Platform Described in Nature - Scientific Reports (ASX:PYC)

Phylogica is pleased to announce a peer-reviewed publication on our proprietary Cell Penetrating Peptide (CPP) platform in Nature Scientific Reports. The article describes the ability of Phylogica&rsq...read more

Phylogica Announces Article: Delivering Cancer Treatment Inside Cells - Nature Oncogene (ASX:PYC)

6 August 2018: Phylogica is pleased to announce the publication of an article in Nature Oncogene by A/Prof Pilar Blancafort describing the impact of Phylogica’s Cell Penetrating Peptides (CPPs) ...read more

Phylogica Announces Operational Update - June Quarter (ASX:PYC)

PYC is pleased to update shareholders on progress made in the June quarter. Highlights: - Successful completion of the proof of concept validation for our intracellular delivery platform across ...read more

Phylogica Announces Achievement of Major Milestone - Successful In Vivo Cre Delivery (ASX:PYC)

PYC is pleased to announce the successful achievement of a major technical milestone in the validation of its intracellular drug delivery platform. Highlights: - PYC has successfully delivered t...read more

Viewing: 136 - 150 of 200 Previous | Next